https://www.selleckchem.com/
A total of 240 patients underwent randomization. We performed a modified intention-to-treat analysis on 231 patients (116 in the control group and 115 in the study group). A higher proportion of patients in the olanzapine group achieved CR in the acute period (78% 59%; = .001), delayed period (74% 47%; .001) and overall period (64% 38%; .001) than in the control group. The proportion of patients with no nausea was significantly higher in the olanzapine group in the acute period (74% 52%; .001), delayed period (74% 47%; .001), and overall